Skip to content

Karine Matevossian, DO

NPI 1174054217ActiveIndividual· Obstetrics & Gynecology, Reproductive Endocrinology· Glenview, IL

Obstetrics & Gynecology, Reproductive Endocrinology (DO) in Glenview, Illinois, licensed in IL, with an NPI issued in March 2017. Ferring Pharmaceuticals Inc. was the largest of 3 companies reporting payments in 2025, $688.28 in all, mostly food and beverage.

Overview

NPI1174054217
StatusActive
Entity typeIndividual
CredentialDO
Sole proprietorNo
NPI issuedMar 21, 2017
Last updated in NPPESOct 30, 2024
Certified by providerOct 25, 2024

Specialties and licenses

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Not in the public enrollment file of Oct 1, 2026

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$688.28 · 23 payments from 3 companies
  • 2024$284.37 · 3 payments from 2 companies

Top paying companies in 2025

CompanyAmountPayments
Ferring Pharmaceuticals Inc.$494.3815
Organon LLC$175.667
Emd Serono, Inc.$18.241

What the 2025 payments were for

  • Food and Beverage$688.28 · 23 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Obstetrics & Gynecology, Reproductive Endocrinology providers in Glenview

All Obstetrics & Gynecology, Reproductive Endocrinology providers in Illinois →